Obesity Affects HDL Metabolism, Composition and Subclass Distribution
暂无分享,去创建一个
H. Scharnagl | A. Borenich | N. Meier-Allard | S. Zelzer | G. Marsche | Julia T. Stadler | S. Lackner | S. Mörkl | H. Mangge | S. Holasek | W. Wonisch | Athina Trakaki | Andrea Borenich
[1] B. Nordestgaard,et al. VLDL Cholesterol Accounts for One-Half of the Risk of Myocardial Infarction Associated With apoB-Containing Lipoproteins. , 2020, Journal of the American College of Cardiology.
[2] G. Marsche,et al. Obesity-Related Changes in High-Density Lipoprotein Metabolism and Function , 2020, International journal of molecular sciences.
[3] G. Heine,et al. Current Understanding of the Relationship of HDL Composition, Structure and Function to Their Cardioprotective Properties in Chronic Kidney Disease , 2020, Biomolecules.
[4] G. Norata,et al. Low Plasma Lecithin: Cholesterol Acyltransferase (LCAT) Concentration Predicts Chronic Kidney Disease , 2020, Journal of clinical medicine.
[5] Daniel M. Rotroff,et al. Bariatric Surgery Improves HDL Function Examined by ApoA1 Exchange Rate and Cholesterol Efflux Capacity in Patients with Obesity and Type 2 Diabetes , 2020, Biomolecules.
[6] H. Scharnagl,et al. HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure. , 2020, Journal of hepatology.
[7] R. Santos,et al. Free cholesterol transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis underlies the U-shape relationship between HDL-cholesterol and cardiovascular disease , 2019, European journal of preventive cardiology.
[8] M. Lehofer,et al. Novel approaches for the assessment of relative body weight and body fat in diagnosis and treatment of anorexia nervosa: A cross-sectional study. , 2019, Clinical nutrition.
[9] G. Sturm,et al. Allergic rhinitis is associated with complex alterations in high-density lipoprotein composition and function. , 2019, Biochimica et biophysica acta. Molecular and cell biology of lipids.
[10] J. Goedecke,et al. HDL Subclass Distribution Shifts with Increasing Central Adiposity , 2019, Journal of obesity.
[11] W. Weger,et al. Abnormal composition and function of high‐density lipoproteins in atopic dermatitis patients , 2018, Allergy.
[12] Raiya Sarwar,et al. Obesity and nonalcoholic fatty liver disease: current perspectives , 2018, Diabetes, metabolic syndrome and obesity : targets and therapy.
[13] M. Lehofer,et al. Gut microbiota, dietary intakes and intestinal permeability reflected by serum zonulin in women , 2018, European Journal of Nutrition.
[14] C. Drevon,et al. Soluble Leptin Receptor Predicts Insulin Sensitivity and Correlates With Upregulation of Metabolic Pathways in Men , 2017, The Journal of clinical endocrinology and metabolism.
[15] G. Gorkiewicz,et al. Gut microbiota and body composition in anorexia nervosa inpatients in comparison to athletes, overweight, obese, and normal weight controls , 2017, The International journal of eating disorders.
[16] G. Pregartner,et al. Adiponectin Predicts High‐Density Lipoprotein Cholesterol Efflux Capacity in Adults Irrespective of Body Mass Index and Fat Distribution , 2017, The Journal of clinical endocrinology and metabolism.
[17] A. Kontush,et al. Antioxidative activity of high-density lipoprotein (HDL): Mechanistic insights into potential clinical benefit , 2017, BBA clinical.
[18] T. Berg,et al. Cholesterol esterification in plasma as a biomarker for liver function and prediction of mortality , 2017, BMC Gastroenterology.
[19] N. Bachl,et al. Standardized Ultrasound Measurement of Subcutaneous Fat Patterning: High Reliability and Accuracy in Groups Ranging from Lean to Obese. , 2017, Ultrasound in medicine & biology.
[20] R. Birner-Gruenberger,et al. Liver disease alters high-density lipoprotein composition, metabolism and function , 2016 .
[21] L. Opie,et al. Association between ethnicity and obesity with high-density lipoprotein (HDL) function and subclass distribution , 2016, Lipids in Health and Disease.
[22] P. Scherer,et al. Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk. , 2016, Cell metabolism.
[23] T. Lohman,et al. Subcutaneous fat patterning in athletes: selection of appropriate sites and standardisation of a novel ultrasound measurement technique: ad hoc working group on body composition, health and performance, under the auspices of the IOC Medical Commission , 2015, British Journal of Sports Medicine.
[24] K. Rye,et al. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export. , 2015, Circulation research.
[25] H. Scharnagl,et al. Dialysis Modalities and HDL Composition and Function. , 2015, Journal of the American Society of Nephrology : JASN.
[26] L. Rohrer,et al. Rapid and Body Weight–Independent Improvement of Endothelial and High-Density Lipoprotein Function After Roux-en-Y Gastric Bypass: Role of Glucagon-Like Peptide-1 , 2015, Circulation.
[27] A. Khera,et al. HDL cholesterol efflux capacity and incident cardiovascular events. , 2014, The New England journal of medicine.
[28] A. S. Al-Goblan,et al. Mechanism linking diabetes mellitus and obesity , 2014, Diabetes, metabolic syndrome and obesity : targets and therapy.
[29] A. Kontush. HDL-mediated mechanisms of protection in cardiovascular disease. , 2014, Cardiovascular research.
[30] Deepak L. Bhatt,et al. Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. , 2014, The New England journal of medicine.
[31] M. Zaki,et al. Association of serum paraoxonase enzyme activity and oxidative stress markers with dyslipidemia in obese adolescents , 2014, Indian journal of endocrinology and metabolism.
[32] Kazuto Nakamura,et al. Adipokines: a link between obesity and cardiovascular disease. , 2014, Journal of cardiology.
[33] D. Kiortsis,et al. Adiponectin and lipoprotein metabolism , 2013, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[34] E. Fisher,et al. Lipoprotein Metabolism, Dyslipidemia, and Nonalcoholic Fatty Liver Disease , 2013, Seminars in Liver Disease.
[35] G. De Pergola,et al. Obesity as a Major Risk Factor for Cancer , 2013, Journal of obesity.
[36] L. Aronne,et al. Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association. , 2013, Journal of clinical lipidology.
[37] M. Garelnabi,et al. Antioxidant and Anti-Inflammatory Role of Paraoxonase 1: Implication in Arteriosclerosis Diseases , 2012, North American journal of medical sciences.
[38] Meinrad Lindschinger,et al. Oxidative stress increases continuously with BMI and age with unfavourable profiles in males , 2012, The aging male : the official journal of the International Society for the Study of the Aging Male.
[39] R. Dullaart,et al. Increased LCAT activity and hyperglycaemia decrease the antioxidative functionality of HDL , 2012, European journal of clinical investigation.
[40] A. Kontush,et al. Biological activities of HDL subpopulations and their relevance to cardiovascular disease. , 2011, Trends in molecular medicine.
[41] J. S. Elmendorf,et al. Evidence That Chromium Modulates Cellular Cholesterol Homeostasis and ABCA1 Functionality Impaired by Hyperinsulinemia—Brief Report , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[42] D. Rader,et al. Adiponectin is associated with favorable lipoprotein profile, independent of BMI and insulin resistance, in adolescents. , 2011, The Journal of clinical endocrinology and metabolism.
[43] J. Tanabe,et al. Insulin suppresses HDL-mediated cholesterol efflux from macrophages through inhibition of neutral cholesteryl ester hydrolase and ATP-binding cassette transporter G1 expressions. , 2010, Journal of atherosclerosis and thrombosis.
[44] A. Tall. Functions of cholesterol ester transfer protein and relationship to coronary artery disease risk. , 2010, Journal of clinical lipidology.
[45] L. Bajnok,et al. Human Paraoxonase-1 Activity in Childhood Obesity and Its Relation to Leptin and Adiponectin Levels , 2010, Pediatric Research.
[46] J. Frystyk,et al. Adiponectin and Lipoprotein Particle Size , 2009, Diabetes Care.
[47] S. Kihara,et al. Adiponectin deficiency suppresses ABCA1 expression and ApoA-I synthesis in the liver. , 2008, FEBS letters.
[48] D. Rader,et al. Obesity and atherogenic dyslipidemia. , 2007, Gastroenterology.
[49] J. Griffin,et al. Endothelial and antithrombotic actions of HDL. , 2006, Circulation research.
[50] Thomas D. Giles,et al. Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[51] J. Schneider,et al. Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo. , 2005, Diabetes care.
[52] Stephan Rössner,et al. Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: executive summary. , 2004, Circulation.
[53] P. Barter,et al. Antiinflammatory Properties of HDL , 2004 .
[54] Charles C Schwartz,et al. Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans Published, JLR Papers in Press, May 16, 2004. DOI 10.1194/jlr.M300511-JLR200 , 2004, Journal of Lipid Research.
[55] T. Saruta,et al. Relationships between serum soluble leptin receptor level and serum leptin and adiponectin levels, insulin resistance index, lipid profile, and leptin receptor gene polymorphisms in the Japanese population. , 2004, Metabolism: clinical and experimental.
[56] B. Howard,et al. Obesity and dyslipidemia. , 2003, Endocrinology and metabolism clinics of North America.
[57] R. Dullaart,et al. Alterations in high‐density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins , 2003, European journal of clinical investigation.
[58] F. Tatzber,et al. Dual method for the determination of peroxidase activity and total peroxides-iodide leads to a significant increase of peroxidase activity in human sera. , 2003, Analytical biochemistry.
[59] R. Lüdtke,et al. Effects of One Week Juice Fasting on Lipid Metabolism: A Cohort Study in Healthy Subjects , 2003, Complementary Medicine Research.
[60] S. Kaser,et al. Relationship Between Cholesteryl Ester Transfer Protein and Atherogenic Lipoprotein Profile in Morbidly Obese Women , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[61] T. Saruta,et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. , 2002, Clinical science.
[62] A. Jonas,et al. Binding affinity and reactivity of lecithin cholesterol acyltransferase with native lipoproteins. , 1999, Biochemical and biophysical research communications.
[63] J. Frohlich,et al. Understanding the mechanism of LCAT reaction may help to explain the high predictive value of LDL/HDL cholesterol ratio. , 1998, Physiological research.
[64] M. McDonnell,et al. Cholesteryl ester transfer protein (CETP) mRNA abundance in human adipose tissue: relationship to cell size and membrane cholesterol content. , 1995, Journal of lipid research.
[65] G. Franceschini,et al. Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[66] R. Mahley,et al. Plasma lipoproteins: apolipoprotein structure and function. , 1984, Journal of lipid research.
[67] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.
[68] W. Brown,et al. Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein. , 1972, Biochemical and biophysical research communications.
[69] J. Glomset,et al. The plasma lecithins:cholesterol acyltransferase reaction. , 1968, Journal of lipid research.